| |
Latest 10 SEC filings (by transaction date) for TNXP within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,309,911 | |
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,903,680 | |
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 235,320 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,309,911 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,903,680 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 235,320 | |
Feb 29/24 | Feb 27/24 | Saenger Bradley | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 282,000 | |
Feb 29/24 | Feb 27/24 | Saenger Bradley | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 282,000 | |
Feb 29/24 | Feb 27/24 | Morris Jessica Edgar | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 317,000 | |
Feb 29/24 | Feb 27/24 | Morris Jessica Edgar | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 317,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TNXP within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,309,911 | |
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,903,680 | |
Mar 6/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 235,320 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,309,911 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,903,680 | |
Feb 29/24 | Feb 27/24 | Lederman Seth | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 235,320 | |
Feb 29/24 | Feb 27/24 | Saenger Bradley | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 282,000 | |
Feb 29/24 | Feb 27/24 | Saenger Bradley | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 282,000 | |
Feb 29/24 | Feb 27/24 | Morris Jessica Edgar | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 317,000 | |
Feb 29/24 | Feb 27/24 | Morris Jessica Edgar | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 317,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |